# Boston Scientific Corporation (BSX) — Q4-2023 Earnings Results

**Report date:** 2024-01-31 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2023

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Up 3.0%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.34 | N/A | -33.46% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management conveyed a cautious optimism about future growth opportunities. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management highlighted ongoing investments in innovation and market expansion.

> They acknowledged the challenges faced in the quarter but remain focused on long-term growth.

> The team expressed confidence in their strategic initiatives despite the EPS miss.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

The earnings report indicates that Boston Scientific faced challenges this quarter, particularly reflected in their EPS miss. However, the stock rose by 3% likely due to positive sentiment around their long-term strategies and investments in innovation. Investors may be encouraged by management's focus on growth despite the short-term setback.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2023_